ATC Group: B03BB01 Folic acid

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B03BB01 in the ATC hierarchy

Level Code Title
1 B Blood and blood forming organs
2 B03 Antianemic preparations
3 B03B Vitamin B12 and folic acid
4 B03BB Folic acid and derivatives
5 B03BB01 Folic acid

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 0.4 mg
PAREN - Parenteral 10 mg

Active ingredients in B03BB01

Active Ingredient Description
Folic acid

Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues.

Related product monographs

Title Information Source Document Type  
FOLIC ACID / ACCORD Tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FOLICIL Tablet MPI, EU: SmPC

Medicines in this ATC group

Australia (AU)

Austria (AT)

Croatia (HR)

Cyprus (CY)

Estonia (EE)

France (FR)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Poland (PL)

Romania (RO)

Spain (ES)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.